Expression of Signaling Lymphocytic Activation Molecule-Associated Protein interrupts IFN-g production in human tuberculosis

PASQUINELLI VIRGINIA; QUIROGA M. FLORENCIA; MARTÍNEZ GUSTAVO J; CASTRO ZORRILLA LILIANA; MUSELLA ROSA M; BRACCO MARÍA M; BELMONTE LILIANA; MALBRÁN ALEJANDRO; FAINBOIM LEONARDO; SIELING PETER A; GARCÍA VERÓNICA E

JOURNAL OF IMMUNOLOGY

AMER ASSOC IMMUNOLOGISTS

Año: 2004 vol. 172 p. 1177 - 1185

0022-1767

Production of the Th1 cytokine IFN-gamma by T cells is considered crucial for immunity against Mycobacterium tuberculosis infection. We evaluated IFN-gamma production in tuberculosis in the context of signaling molecules known to regulate Th1 cytokines. Two populations of patients who have active tuberculosis were identified, based on their T cell responses to the bacterium. High responder tuberculosis patients displayed significant M. tuberculosis-dependent T cell proliferation and IFN-gamma production, whereas low responder tuberculosis patients displayed weak or no T cell responses to M. tuberculosis. The expression of the signaling lymphocytic activation molecule (SLAM)-associated protein (SAP) on cells from tuberculosis patients was inversely correlated with IFN-gamma production in those individuals. Moreover, patients with a nonfunctional SAP gene displayed immune responses to M. tuberculosis similar to those of high responder tuberculosis patients. In contrast to SAP, T cell expression of SLAM was directly correlated with responsiveness to M. tuberculosis Ag. Our data suggest that expression of SAP interferes with Th1 responses whereas SLAM expression contributes to Th1 cytokine responses in tuberculosis. The study further suggests that SAP and SLAM might be focal points for therapeutic modulation of T cell cytokine responses in tuberculosis.